| Literature DB >> 31496313 |
Zhiwei Shen1,2, Yujiao Wang1,2, Zhen Guo1,2, Tingyuan Tan1,2, Yi Zhang1,3.
Abstract
Tyrosinase is a key enzyme involved in melanin synthesis. Therefore, various tyrosinase inhibitors have been screened by researchers in recent years. In the present study, we discovered a novel tyrosinase inhibitor, a peptide ECGYF (named EF-5), with free radical scavenging ability. The effect of tyrosinase inhibition by EF-5 was stronger than that of arbutin and glutathione, when analyzed both in vitro (IC50: 0.46 mM) and in vivo. The UV-Vis absorption and circular dichroism spectroscopies indicated that EF-5 interacted with tyrosinase in a different way as that of glutathione. The results of molecular docking showed that the binding between EF-5 and tyrosinase was determined majorly by hydrogen bonds and hydrophobic interactions. EF-5 had also retained its ability to scavenge both hydroxyl and superoxide radicals in vitro and was found to be nontoxic to cells, as revealed by the MTT assay. These features suggested that the EF-5 peptide may serve as a safe and effective alternative as a tyrosinase inhibitor.Entities:
Keywords: Melanin; radical scavenging; tyrosinase inhibitory peptide
Mesh:
Substances:
Year: 2019 PMID: 31496313 PMCID: PMC6746264 DOI: 10.1080/14756366.2019.1661401
Source DB: PubMed Journal: J Enzyme Inhib Med Chem ISSN: 1475-6366 Impact factor: 5.051
Figure 1.Inhibition ability of the peptide EF-5 on tyrosinase. (A) A picture of the tyrosine-saturated PBS solutions after mixing with tyrosinase (1 KU/ml) and EF-5 (concentrations varied in 0–6.2 mM). Control group contains only tyrosinase. EF-5 group contains only EF-5 (6.2 mM) and tyrosinase (1 KU/ml) for 24 h. (B) Molecular structure of peptide EF-5. (C) The absorbance at 475 nm of the solutions shown in (A). The absorbance of tyrosinase was subtracted from each group. N = 5. (D) The ratio of tyrosinase activity in the melanin production inhibited by EF-5 plotted vs EF-5 concentration. N = 3.
Figure 2.(A–C) Evolution of OD value at 475 nm in the tyrosine solutions mixed with tyrosinase and its inhibitors, Arbutin (A), Glutathione (B), or EF-5 (C). (D) The plot of the percentage of enzyme activity (Vss) vs the tyrosinase concentration [I]. IC50 of the inhibitors were directly obtained from the plots.
Figure 3.(A) Effect of inhibitors on cell viability. The concentrations of all inhibitors were 2.5 mM in PBS. (B) Comparison on melanin production in melanocyte with the treatment of inhibitors. N = 3. The error bars represent means ± SD
Figure 4.The UV-Vis absorption spectra of tyrosinase in the presence of (A) EF-5 and (B) glutathione, and the CD spectra of tyrosinase in the presence of (C) EF-5 and (D) Glutathione. The concentrations of EF-5, glutathione and tyrosinase were 0.2 mg/ml.
Figure 5.Molecular docking model of tyrosinase and EF-5. (A) The 3 D map of EF-5 docking in the tyrosinase activity center. (B) The 2 D projection of EF-5 and tyrosinase docking model. The image was generated in LigPlot.
Figure 6.Scavenging effect (%) of EF-5 and glutathione on hydroxyl radical (A) and superoxide radical (B). N = 3.